This Solicitation opportunity from Florida was posted on July 9, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Bio-Rad Laboratories Geenius™ System and Sickle Cell kits

Closed

EXP2682State & Local

Submission Closed07/14/2026, 06:30:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325413

New

DIBBS

TEST KIT, CORONAVIRUS D

Solicitation # SPE2DS-26-T-340F

This contract is for the procurement of 10 cases of Abbott BinaxNOW COVID-19 Antigen self-test kits for over-the-counter at-home use. Each case contains 12 kits, with two tests per kit. The items must be stored between 2 and 30 degrees Celsius and must adhere to Medical Marking Standard No. 1, including specific labels for the date of manufacture, expiration, and contract or lot numbers. The delivery requirement is 20 days after the order is placed. The product has a non-extendable shelf life of 12 months, and no more than one month may have elapsed from the date of manufacture to the date of delivery to the government. Packaging must meet commercial standards to ensure safe delivery and protection from damage, and the contract incorporates specific DLA technical, quality, and packaging requirements.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Drug Testing Kits - DRC270048 - APA

Solicitation # SRC0000040482

This solicitation, identified as DRC270048 - APA under solicitation number SRC0000040482, is for the procurement of drug testing kits. The contract is issued by the state of Ohio through the Drc100000 Operation Support Center Drcfra and will be performed within the state of Ohio. The opportunity was posted on August 14, 2026, with a response deadline set for August 26, 2026. This is categorized as a solicitation for a state, local, or education government entity.

Drc100000 Operation Support Center Drcfra

POSTED

DEADLINE

Supplies for Vitros Chemistry Analyzers - Naval Hospital Sigonella

Solicitation # HT940626QE091

The Defense Health Agency is seeking an Indefinite Delivery Indefinite Quantity Firm Fixed Price supply contract for chemistry and immunochemistry analyzer materials to support the Naval Hospital Sigonella. These supplies are essential for performing critical care testing, including kidney function, liver enzymes, cardiac markers, and BHCG testing, which are vital for emergent patient care and general hospital operations. The contract requires the delivery of materials for two Vitros 7600 analyzers, with a strict mandate that supplies be delivered within four days of order placement while maintaining specific temperature controls. This solicitation, identified by number HT940626QE091 under NAICS code 325413, is open for proposals until August 30, 2026.

Defense Health Agency

POSTED

DEADLINE

NOI to Sole Source AMICUS Apheresis Reagents & Consumables

Solicitation # HT941026N0107

The Defense Health Agency Contracting Activity intends to award a firm-fixed-price sole source contract to Fenwal, Inc. for the drop shipment of FDA Fenwal Amicus Apheresis Reagents. This procurement is designed to support the operational requirements of the Naval Hospital Okinawa in Japan, specifically for the collection, treatment, and sustainment of blood platelet products. These reagents and processing sets are critical for pathogen reduction processes mandated by the FDA to ensure patient safety and mission readiness. The contract covers a delivery period from October 1, 2026, through September 30, 2027, with delivery routed through the DLA Troop Support XDock West Project in Ontario, California. Classified under NAICS code 325413, the acquisition is being executed as a sole source because Fenwal, Inc. is identified as the only manufacturer capable of meeting the government's requirements. Interested parties wishing to challenge this intent must submit a detailed capability statement by August 28, 2026.

Defense Health Agency Hcd West

POSTED

DEADLINE

BRAND NAME OR EQUAL Flow Cytometry Reagents for the MPLS VA

Solicitation # 36C26326R0072

Solicitation 36C26326R0072 is a five-year Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract issued by the Department of Veterans Affairs, Network Contracting Office 23, for the procurement of brand-name or equal flow cytometry reagents. The contract is designed to support clinical immunophenotyping at the Minneapolis VA Health Care System, with a total period of performance running from October 1, 2026, through September 30, 2031. This duration consists of a base period followed by four one-year ordering periods. The procurement is justified as a sole-source award under FAR 6.103-1 and 12.102(a) because the required Becton Dickinson (BD) reagents are proprietary and the only products compatible with the facility's existing BD FACSCanto, FACSLyric, and FACS Lyse Wash Assistant instrumentation. The scope of work involves the supply of a specific catalog of BD reagents, including various CD antigens and fluorochromes, with estimated annual quantities ranging from 2 to 60 units per item. All deliveries and performance will occur at the Minneapolis VA Health Care System located at One Veterans Drive, Minneapolis, MN 55417. The contract is managed by Contracting Officer Traci Johannes. While the solicitation specifies that reagents must meet FDA regulatory categories such as In Vitro Diagnostic (IVD) or Analyte Specific Reagent (ASR), no specific pricing, CLIN structures, or socioeconomic set-asides are applied. Responses are required in the form of a capabilities statement submitted electronically by the August 2026 deadline.

Network Contract Office 23 (36C263)

POSTED

DEADLINE

Procurement of commercial-off-the-shelf (COTS) proprietary BioFire diagnostic assay kits and refurbished systems

Solicitation # N6817126QN076

The Naval Supply Systems Command Fleet Logistics Center Sigonella intends to award a firm-fixed-price, sole-source purchase order to Bio Fire Defense, LLC for the procurement of proprietary BioFire diagnostic assay kits and four refurbished FilmArray 2.0 systems. This acquisition supports the Naval Medical Research Unit Europe, Africa, Central in its infectious disease surveillance and research operations across Europe, Africa, and the Middle East. The required materials include various specialized panels for global fever, blood culture identification, gastrointestinal, and respiratory diagnostics, all of which must be delivered to NAS II Sigonella, Italy, within 15 calendar days of the order. The sole-source justification is based on the proprietary nature of the consumables and a Foreign Ownership, Control, or Influence mitigation agreement, which mandates that U.S. Federal Government entities procure these specific biological defense assets exclusively through Bio Fire Defense, LLC. While this is a notice of intent for a sole-source award, interested parties may submit capability statements by August 31, 2026. To be considered, respondents must provide evidence of FOCI agreement compliance, the ability to provide exact part numbers without substitutions, cold-chain logistical capabilities for delivery to Italy, and confirmation of valid OEM warranty support.

Navsup Flc Sigonella Naples Office

POSTED

DEADLINE

Supply of Meso Scale V-PLEX 39-Biomarker Diagnostic Kits (5-Pack)The Department of Veterans Affairs, through the Network Contract Office 20, is seeking a subcontract for the supply and delivery of one Meso Scale V-PLEX 39-biomarker diagnostic kit 5-pack. This equipment is required for a specific research study focused on frailty, osteoporosis, and fractures among Veterans with rheumatoid arthritis. To maintain data continuity and ensure technical compatibility, the kit must be manufactured by Meso Scale Diagnostics LLC. The procurement is categorized under NAICS code 325413. The solicitation was posted on August 12, 2026, with a response deadline of August 19, 2026.

260-NETWORK Contract Office 20 (36C260)

POSTED

DEADLINE

Supply of Epi Multiome Reagents for Single-Cell Dual-Omic SequencingThis subcontract with the Department of Veterans Affairs involves the supply of complete Epi Multiome reagent kits designed for single-cell dual-omic sequencing. These kits must be compatible with the Chromium X Series Chip Holder (PN-300598) to enable the simultaneous execution of ATAC-seq and RNA-seq from single cell nuclei. The procurement is managed by the NETWORK Contract Office 02 and is categorized under NAICS code 325413. The place of performance is located in Bronx, New York, with a response deadline set for August 25, 2026.

242-NETWORK Contract Office 02 (36C242)

POSTED

DEADLINE

Supply of DNA-Based Vaginal Pathogen Test KitsThe Department of Veterans Affairs, through Network Contract Office 8, is seeking a subcontractor for the supply of DNA-based vaginal pathogen test kits. These in vitro diagnostic kits must utilize DNA direct probe detection technology to identify Candida species, Gardnerella vaginalis, and Trichomonas vaginalis, and they must be fully compatible with the VPIII microbial identification system. This opportunity falls under NAICS code 325413 and was posted on August 12, 2026. Interested parties must submit their responses by the deadline of August 26, 2026, at 6:00 PM.

248-NETWORK Contract Office 8 (36C248)

POSTED

DEADLINE

6550--Sources Sought: EPI MULTITOME REAGENTS

Solicitation # 36C24226Q0907

The Department of Veterans Affairs is conducting market research through a Sources Sought Notice to identify qualified manufacturers or distributors capable of providing specific genetic sequencing reagents for the James J. Peters VA Medical Center in Bronx, New York. The requirement focuses on Epi Multiome assays and chip kits compatible with the Chromium X Series Chip Holder. These tools are used for dual-omic profiling to link epigenetic regulatory mechanisms with active gene transcription, supporting research in gene regulatory networks, cell type annotation, and disease development. Interested businesses under NAICS code 325413 must submit their capabilities and business size status to Jonatan Rondon by August 25, 2026, at 16:00 EST. The government is seeking detailed information regarding the respondent's role as a manufacturer or distributor, federal contract holdings, and the domestic or foreign origin of the products. This notice is for planning purposes only and does not constitute a formal solicitation or a commitment to award a contract.

242-NETWORK Contract Office 02 (36C242)

POSTED

DEADLINE

Vela Diagnostics Sequencing System for HIV-1 Genotype Testing

Solicitation # HT9426-26-NOI-5892

The Defense Health Agency Contracting Activity, on behalf of the Walter Reed Army Institute of Research, intends to award a firm fixed price sole source contract to Vela Diagnostics, USA INC. This procurement is for the Sentosa SQ Next Generation Sequencing system and associated reagents, consumables, and maintenance required for FDA approved HIV-1 genotype testing. This testing is critical for monitoring drug resistance mutations in HIV-1 infected soldiers and their beneficiaries within a CAP accredited laboratory. The government has identified Vela Diagnostics as the only responsible source capable of meeting these requirements due to the FDA approval of the system and the necessity of a reagent rental agreement, which third party vendors are not authorized to provide. While this is a notice of intent to sole source, the government will consider capability statements from other vendors until August 27, 2026, to determine if a competitive procurement is in the best interest of the government.

Army Medical Resources Acq Activity

POSTED

DEADLINE

6550-- Meso Scale V-Plex 39-biomarker Diagnostic Kit Notice of Intent to Sole Source

Solicitation # 36C26026Q0952

The Department of Veterans Affairs, VISN 20 Contracting Activity, intends to award a sole source, firm-fixed price contract to Meso Scale Diagnostics LLC for one Meso Scale V-PLEX 39-biomarker kit 5 pack. This procurement, categorized under NAICS code 325413 for In-Vitro Diagnostic Substance Manufacturing, is necessary for analyzing biospecimens in a study regarding the impacts of frailty on osteoporosis and fractures in veterans with rheumatoid arthritis. The kits are required to be from this specific manufacturer to ensure scientific comparability with collaborator data and compatibility with existing VA equipment. The anticipated award date for this action is August 28, 2026. This notice serves as a public announcement of the intent to negotiate exclusively with Meso Scale Diagnostics LLC and is not a request for competitive proposals. The primary point of contact for this procurement is Contract Officer Amy Kuczajda, and the action is being managed through the Network Contract Office 20 based in Vancouver, Washington.

260-NETWORK Contract Office 20 (36C260)

POSTED

7 days ago

DEADLINE

in 24 minutes

AI Contract Overview

The Florida Department of Health, Bureau of Public Health Laboratories, is seeking to procure the Bio-Rad Laboratories Geenius™ System and associated Sickle Cell kits under a single-source purchase authorized under Rule 60A-1.045, Florida Administrative Code, to fulfill critical diagnostic needs for HIV confirmatory testing and newborn screening. The Geenius™ System is designated as the sole FDA-approved HIV-1/HIV-2 supplemental differentiation assay available in the U.S. market that has been validated in-house for use with oral fluid, in addition to whole blood, serum, and plasma, ensuring full compliance with the CDC 2014 HIV Diagnostic Algorithm. The system will be used to confirm initial positive HIV screens across the state’s public health laboratory network, enabling accurate, timely diagnosis and improved patient outcomes. The procurement covers a three-year term with an estimated contract value of $460,000 and is identified under NAICS code 12161500 for indicators and reagents, with additional commodity codes applicable to clinical diagnostic reagents and test kits. This is a non-competitive solicitation, as the Geenius™ System’s unique validation and regulatory status preclude the availability of equivalent alternatives, eliminating the need for competitive evaluation factors or award criteria. The contract is administered through the FDOH’s Bureau of Public Health Laboratories, with Benjamin Roberts listed as the point of contact for inquiries and submissions. The solicitation was posted on June 15, 2026, with a response deadline of July 9, 2026, and applies exclusively to the state of Florida, where the system will be deployed and operated. No packaging, inspection, delivery, or invoicing specifications are detailed beyond the requirement for the full Geenius™ system and controls to be delivered in a manner consistent with the system’s operational use in a public health laboratory setting. Vendors are requested to confirm their ability to supply the required commodities, but no formal proposal format or submission instructions are provided, as this is a single-source justification rather than a competitive solicitation.

General Info

Florida Department of Health seeks FDA-approved HIV-1/HIV-2 assay system, single source purchase.

Agency

Florida → Department of HealthView Agency

NAICS

325413 - In-Vitro Diagnostic Substance ManufacturingView NAICS

Place of Performance

FL, USA

Set-Aside

NONE

Documents

(2)

PUR 7778 Single Source Contract Notice for Bio-Rad Laboratories Geenius System

PDF•justification-and-authorization

EXP2682 PUR7776 Single Source Purchase Description for Bio-Rad Geenius System

PDF•justification-and-authorization

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedJul 9

Solicitation

Response DeadlineJul 14

Deadline has passed

Submission Closed

07/14/2026, 06:30:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyFlorida → Department of Health

Contacts1 person available

OfficeN/A

Organization / Agency

Florida → Department of Health

View Agency Profile

Office AddressN/A

Contacts

Benjamin Roberts

contact@example.gov

+1 (555) 000-0000

Full Description

The FDOH BPHL has a need to purchase a FDA approved confirmatory assay system to perform HIV-1/HIV-2 Supplemental differentiation assay testing to confirm HIV infection in patients testing positive on an initial screen. The assay must be able to test whole blood, serum, plasma, and in-house validated oral fluid to conform to the CDC 2014 HIV Diagnostic Algorithm guidelines. In accordance with Chapter 60A-1.045, Florida Administrative Code, the Florida Department of Health, BPHL, requests authorization to purchase, as a single source, the Bio-Rad Laboratories Geenius™ System assays and controls.